ClinicalTrials.Veeva

Menu

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test (EVASEF)

C

Centre Hospitalier Universitaire, Amiens

Status

Completed

Conditions

Sexual Dysfunction
Epidemiology

Treatments

Other: questionnary

Study type

Interventional

Funder types

Other

Identifiers

NCT05701020
PI2019_843_0105

Details and patient eligibility

About

Human Papilloma virus is the most common sexual infection in women, which can leads to cervical lesion and cervical cancer. Pap test is recommanded in women of 25 years old until 65 years old in order to screen subclinic lesions and improve prognosis. Yet, scientific knowledge about chronic disease showed negative consequences on quality of life.

However, no study until now has striven to evaluate the consequences of an abnormal pap test on sexuality in adult women. The aim of this study is to evaluate if an abnormal pap test have an impact on the sexual functions in women because of the anxiety and psychological consequences of the diagnosis

Enrollment

90 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult women with an abnormal pap test.
  • Diagnosis known 4 to 12 weeks before the appointment for colposcopy

Exclusion criteria

  • Cervical cancer
  • Pregnancy

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

90 participants in 1 patient group

Adult women with an abnormal pap test
Experimental group
Treatment:
Other: questionnary

Trial contacts and locations

1

Loading...

Central trial contact

Arthur Foulon, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems